查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594655

眼药水市场：按类型、类别、最终用户、适应症分类 - 全球预测 2025-2030

Ophthalmic Drops Market by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops, Dilation Drops), End User, Indications - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年滴眼剂市场规模为12.2亿美元，预计2024年将达到13.1亿美元，复合年增长率为7.11%，2030年将达到19.8亿美元。

眼药水市场专注于治疗各种眼部疾病的产品，如干燥、过敏、感染疾病和青光眼。市场范围从非处方药到处方药，应用广泛，包括润滑、感染疾病控制、过敏缓解和眼压调节等。这种多样化的应用程式满足了个人最终用户的需求，例如患有慢性病的患者或寻求即时缓解的患者，以及机构相关人员，例如医院和诊所。主要成长动力包括人口老化导致与老龄化相关的眼部疾病发病率增加、数位萤幕的广泛使用导致数位眼睛疲劳以及药物输送系统的技术进步。最近的进展，特别是不含防腐剂的配方和新的药物传递机制，引起了人们的极大兴趣。医疗基础设施发达、眼健康意识不断增强的新兴国家市场拓展存在潜在商机。此外，远端医疗和线上药局为分发和教育提供了不断发展的平台，特别是在偏远地区。然而，严格的监管标准、长期使用的潜在副作用以及价格敏感的学名药的竞争等挑战正在阻碍市场成长。创新机会包括开发同时解决多种症状的多活性製剂、透过易于使用的输送系统来提高患者的依从性，以及人工智慧驱动的个人化治疗方法。投资生物有效性和缓释性的研究可以提供竞争优势。眼药水市场具有弹性并有望成长，平衡创新与监管和定价挑战。在技​​术进步、对消费者安全的关注以及对整个医疗保健领域预防保健的日益关注的推动下，市场持续充满活力。解决这些因素对于有效利用市场机会至关重要。

主要市场统计
基准年[2023] 12.2亿美元
预测年份 [2024] 13.1亿美元
预测年份 [2030] 19.8亿美元
复合年增长率（%） 7.11%

市场动态：揭示快速发展的眼药水市场的关键市场洞察

供需的动态交互作用正在改变眼药水市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 人群中眼科疾病和眼部感染疾病的盛行率上升
    • 世界人口老化不断加剧，随之而来的眼科手术数量也增加。
    • 由于萤幕时间增加，儿童和青少年的视力问题增加
  • 市场限制因素
    • 眼药水的全身副作用
  • 市场机会
    • 眼药水的新研发方法
    • 加大眼科药品投入
  • 市场挑战
    • 患者报告的眼药水问题和产品召回

波特五力：驾驭眼药水市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解眼药水市场的外部影响

外部宏观环境因素对眼药水市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解眼药水市场竞争状况

对眼药水市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵眼药水市场供应商绩效评估

FPNV定位矩阵是评估眼药水市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘眼药水市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对眼药水市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中眼部疾病和眼部感染疾病的盛行率增加
      • 全球人口老化不断加剧，眼科手术数量也随之增加。
      • 由于萤幕时间增加，儿童和青少年的视力问题增加
    • 抑制因素
      • 眼药水的全身副作用
    • 机会
      • 眼药水的新研发方法
      • 加大眼科药品投入
    • 任务
      • 患者报告的眼药水问题和产品召回
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 眼药水市场：依类型

  • 非处方眼药水
  • 处方眼药水

第七章 眼药水市场：依类别

  • 麻醉眼药水
  • 抗生素眼药水
  • 肿胀眼药水
  • 青光眼眼药水
  • 类固醇滴注

第八章 眼药水市场：依最终用户分类

  • 眼科诊所
  • 医院
  • 医疗机构
  • 调查机构

第九章依适应症分類的眼药水市场

  • 老龄化黄斑部病变
  • 白内障
  • 青光眼
  • 发炎疾病
  • 屈光不正

第十章 北美、南美眼药水市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太眼药水市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的眼药水市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Akorn, Inc.
  • Alcon Inc.
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Bausch & Lomb Incorporated
  • Catalent, Inc.
  • CVS Health
  • Duopharma Biotech Berhad
  • Geri-Care Pharmaceuticals Corp.
  • Honeywell International Inc.
  • ImprimisRx
  • Johnson & Johnson Services, Inc.
  • KC Pharmaceuticals, Inc.
  • Mankind Pharma Ltd.
  • Mylan NV
  • Novartis AG
  • OCuSOFT, Inc.
  • Orimed Pharma Inc.
  • Pfizer, Inc.
  • Preferred Pharmaceuticals Inc.
  • Prestige Consumer Healthcare Inc.
  • ROHTO Pharmaceutical Co., Ltd.
  • Sager Pharma Kft.
  • Santen Pharmaceutical Co., Ltd.
  • Similasan Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt
Product Code: MRR-814AB2699980

The Ophthalmic Drops Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.31 billion in 2024, and is projected to grow at a CAGR of 7.11%, to USD 1.98 billion by 2030.

The ophthalmic drops market focuses on products designed for treating a variety of eye conditions such as dryness, allergies, infections, and glaucoma. The market's scope extends from over-the-counter formulations to prescription medications and spans diverse applications including lubrication, infection control, allergy relief, and intraocular pressure regulation. This diversity in application caters to individual end-users, such as patients with chronic conditions or those seeking immediate relief, and institutional stakeholders like hospitals and clinics. Key growth drivers include an aging population leading to an increased incidence of age-related eye disorders, widespread digital screen usage leading to digital eye strain, and technological advancements in drug delivery systems. Recent advancements, particularly in preservative-free formulations and novel drug delivery mechanisms, are generating considerable interest. Potential opportunities lie in expanding the market in emerging economies with growing healthcare infrastructure and increased awareness about ocular health. Furthermore, telemedicine and online pharmacies present a growing platform for distribution and education, especially in remote regions. However, market growth is hindered by challenges such as stringent regulatory standards, potential side effects associated with long-term use, and significant competition from generic products that drive price sensitivity. Innovation opportunities include developing multi-action formulations that address several symptoms at once, improving patient compliance through user-friendly delivery systems, and leveraging AI for personalized treatment regimens. Investment in research focused on bioavailability and extended-release formulations could offer competitive advantages. The ophthalmic drops market is resilient and poised for growth, balancing innovation with regulatory and pricing challenges. It remains dynamic, driven by technological advancements, an emphasis on consumer safety, and an increasing inclination toward preventive care within the healthcare continuum. Addressing these factors will be central to leveraging market opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.31 billion
Forecast Year [2030] USD 1.98 billion
CAGR (%) 7.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Drops Market

The Ophthalmic Drops Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Prevalence of Ophthalmic Disease and Eye Infection among the Population
    • Growing Old Age Population and Associated Eye-Surgeries Worldwide
    • Growth of Vision Problems in Kids and Younger Population due to More Screen Time
  • Market Restraints
    • Systemic Side Effects of Ophthalmic Drops
  • Market Opportunities
    • New Research & Development Approach to Ophthalmic Drops
    • Increase in Investment for Ophthalmology Medication
  • Market Challenges
    • Patient-Reported Problems Related to Eye Drop Instillation and Product Recall

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Drops Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Drops Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Drops Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Drops Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Drops Market

A detailed market share analysis in the Ophthalmic Drops Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Drops Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Drops Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Drops Market

A strategic analysis of the Ophthalmic Drops Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drops Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Akorn, Inc., Alcon Inc., Amneal Pharmaceuticals, Inc., Apotex Inc., Bausch & Lomb Incorporated, Catalent, Inc., CVS Health, Duopharma Biotech Berhad, Geri-Care Pharmaceuticals Corp., Honeywell International Inc., ImprimisRx, Johnson & Johnson Services, Inc., KC Pharmaceuticals, Inc., Mankind Pharma Ltd., Mylan N.V., Novartis AG, OCuSOFT, Inc., Orimed Pharma Inc., Pfizer, Inc., Preferred Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co., Ltd., Sager Pharma Kft., Santen Pharmaceutical Co., Ltd., Similasan Corporation, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drops Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Over-the-counter Eye Drops and Prescription Eye Drops.
  • Based on Category, market is studied across Anesthetic Drops, Antibiotic Drops, Dilation Drops, Glaucoma Drops, and Steroid Drops.
  • Based on End User, market is studied across Eye Clinic, Hospitals, Medical Institutes, and Research Organizations.
  • Based on Indications, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Ophthalmic Disease and Eye Infection among the Population
      • 5.1.1.2. Growing Old Age Population and Associated Eye-Surgeries Worldwide
      • 5.1.1.3. Growth of Vision Problems in Kids and Younger Population due to More Screen Time
    • 5.1.2. Restraints
      • 5.1.2.1. Systemic Side Effects of Ophthalmic Drops
    • 5.1.3. Opportunities
      • 5.1.3.1. New Research & Development Approach to Ophthalmic Drops
      • 5.1.3.2. Increase in Investment for Ophthalmology Medication
    • 5.1.4. Challenges
      • 5.1.4.1. Patient-Reported Problems Related to Eye Drop Instillation and Product Recall
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmic Drops Market, by Type

  • 6.1. Introduction
  • 6.2. Over-the-counter Eye Drops
  • 6.3. Prescription Eye Drops

7. Ophthalmic Drops Market, by Category

  • 7.1. Introduction
  • 7.2. Anesthetic Drops
  • 7.3. Antibiotic Drops
  • 7.4. Dilation Drops
  • 7.5. Glaucoma Drops
  • 7.6. Steroid Drops

8. Ophthalmic Drops Market, by End User

  • 8.1. Introduction
  • 8.2. Eye Clinic
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Ophthalmic Drops Market, by Indications

  • 9.1. Introduction
  • 9.2. Age-Related Macular Degeneration
  • 9.3. Cataract
  • 9.4. Glaucoma
  • 9.5. Inflammatory Diseases
  • 9.6. Refractive Disorders

10. Americas Ophthalmic Drops Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Ophthalmic Drops Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Ophthalmic Drops Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Akorn, Inc.
  • 3. Alcon Inc.
  • 4. Amneal Pharmaceuticals, Inc.
  • 5. Apotex Inc.
  • 6. Bausch & Lomb Incorporated
  • 7. Catalent, Inc.
  • 8. CVS Health
  • 9. Duopharma Biotech Berhad
  • 10. Geri-Care Pharmaceuticals Corp.
  • 11. Honeywell International Inc.
  • 12. ImprimisRx
  • 13. Johnson & Johnson Services, Inc.
  • 14. KC Pharmaceuticals, Inc.
  • 15. Mankind Pharma Ltd.
  • 16. Mylan N.V.
  • 17. Novartis AG
  • 18. OCuSOFT, Inc.
  • 19. Orimed Pharma Inc.
  • 20. Pfizer, Inc.
  • 21. Preferred Pharmaceuticals Inc.
  • 22. Prestige Consumer Healthcare Inc.
  • 23. ROHTO Pharmaceutical Co., Ltd.
  • 24. Sager Pharma Kft.
  • 25. Santen Pharmaceutical Co., Ltd.
  • 26. Similasan Corporation
  • 27. Sun Pharmaceutical Industries Ltd.
  • 28. Teva Pharmaceutical Industries Ltd.
  • 29. Wockhardt

LIST OF FIGURES

  • FIGURE 1. OPHTHALMIC DROPS MARKET RESEARCH PROCESS
  • FIGURE 2. OPHTHALMIC DROPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPHTHALMIC DROPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. OPHTHALMIC DROPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. OPHTHALMIC DROPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMIC DROPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMIC DROPS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPHTHALMIC DROPS MARKET DYNAMICS
  • TABLE 7. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY OVER-THE-COUNTER EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY PRESCRIPTION EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY ANESTHETIC DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY ANTIBIOTIC DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY DILATION DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY GLAUCOMA DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY STEROID DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY EYE CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. OPHTHALMIC DROPS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. OPHTHALMIC DROPS MARKET, FPNV POSITIONING MATRIX, 2023